Oral booster probiotic bifidobacteria in SARS-COV-2 patients

Oral booster-single strain probiotic bifidobacteria could be a potential strategy for SARS-CoV-2. This study aims to evaluate the role of oral probiotic Bifidobacterium on moderate/severe SARS-CoV-2 inpatients. In this single-center study, we analyzed data of 44 moderate/severe inpatients with diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozkurt, Hüseyin S, Bilen, Ömer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649091/
https://www.ncbi.nlm.nih.gov/pubmed/34818923
http://dx.doi.org/10.1177/20587384211059677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649091/
https://www.ncbi.nlm.nih.gov/pubmed/34818923
http://dx.doi.org/10.1177/20587384211059677

Ejemplares similares